Cryptococcal glucoxylomannan does not exhibit cross-reactivity in the MVista Histoplasma antigen enzyme immunoassay

David Zhuang; Chadi Hage; Magdia De Jesus; Emily Hackett; Michelle Durkin; Thomas E. Davis; Arturo Casadevall; L. Joseph Wheat

doi:10.1128/CVI.00383-07

Cryptococcal glucoxylomannan does not exhibit cross-reactivity in the MVista Histoplasma antigen enzyme immunoassay

David Zhuang, Chadi Hage, Magdia De Jesus, Emily Hackett, Michelle Durkin, Thomas E. Davis, Arturo Casadevall, L. Joseph Wheat

Research output: Contribution to journal › Article › peer-review

Abstract

The potential for cross-reaction between Cryptococcus neoformans and Histoplasma capsulatum in antigen assays was evaluated. We tested patient samples, spleens from infected mice, and purified polysaccharides in the MVista Histoplasma antigen enzyme immunoassay and cryptococcal antigen latex agglutination system for cross-reactivity, and none was observed.

Original language	English (US)
Pages (from-to)	392-393
Number of pages	2
Journal	Clinical and Vaccine Immunology
Volume	15
Issue number	2
DOIs	https://doi.org/10.1128/CVI.00383-07
State	Published - Feb 2008
Externally published	Yes

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Clinical Biochemistry
Microbiology (medical)

Access to Document

10.1128/CVI.00383-07

Fingerprint Dive into the research topics of 'Cryptococcal glucoxylomannan does not exhibit cross-reactivity in the MVista Histoplasma antigen enzyme immunoassay'. Together they form a unique fingerprint.

Cite this

Cryptococcal glucoxylomannan does not exhibit cross-reactivity in the MVista Histoplasma antigen enzyme immunoassay. / Zhuang, David; Hage, Chadi; Jesus, Magdia De; Hackett, Emily; Durkin, Michelle; Davis, Thomas E.; Casadevall, Arturo; Wheat, L. Joseph.

In: Clinical and Vaccine Immunology, Vol. 15, No. 2, 02.2008, p. 392-393.

Research output: Contribution to journal › Article › peer-review

@article{c7d891046c9a413f88f5f862a1c39de5,

title = "Cryptococcal glucoxylomannan does not exhibit cross-reactivity in the MVista Histoplasma antigen enzyme immunoassay",

abstract = "The potential for cross-reaction between Cryptococcus neoformans and Histoplasma capsulatum in antigen assays was evaluated. We tested patient samples, spleens from infected mice, and purified polysaccharides in the MVista Histoplasma antigen enzyme immunoassay and cryptococcal antigen latex agglutination system for cross-reactivity, and none was observed.",

author = "David Zhuang and Chadi Hage and Jesus, {Magdia De} and Emily Hackett and Michelle Durkin and Davis, {Thomas E.} and Arturo Casadevall and Wheat, {L. Joseph}",

year = "2008",

month = feb,

doi = "10.1128/CVI.00383-07",

language = "English (US)",

volume = "15",

pages = "392--393",

journal = "Clinical and Vaccine Immunology",

issn = "1556-6811",

publisher = "American Society for Microbiology",

number = "2",

}

TY - JOUR

T1 - Cryptococcal glucoxylomannan does not exhibit cross-reactivity in the MVista Histoplasma antigen enzyme immunoassay

AU - Zhuang, David

AU - Hage, Chadi

AU - Jesus, Magdia De

AU - Hackett, Emily

AU - Durkin, Michelle

AU - Davis, Thomas E.

AU - Casadevall, Arturo

AU - Wheat, L. Joseph

PY - 2008/2

Y1 - 2008/2

N2 - The potential for cross-reaction between Cryptococcus neoformans and Histoplasma capsulatum in antigen assays was evaluated. We tested patient samples, spleens from infected mice, and purified polysaccharides in the MVista Histoplasma antigen enzyme immunoassay and cryptococcal antigen latex agglutination system for cross-reactivity, and none was observed.

AB - The potential for cross-reaction between Cryptococcus neoformans and Histoplasma capsulatum in antigen assays was evaluated. We tested patient samples, spleens from infected mice, and purified polysaccharides in the MVista Histoplasma antigen enzyme immunoassay and cryptococcal antigen latex agglutination system for cross-reactivity, and none was observed.

UR - http://www.scopus.com/inward/record.url?scp=40449117739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40449117739&partnerID=8YFLogxK

U2 - 10.1128/CVI.00383-07

DO - 10.1128/CVI.00383-07

M3 - Article

C2 - 18077616

AN - SCOPUS:40449117739

VL - 15

SP - 392

EP - 393

JO - Clinical and Vaccine Immunology

JF - Clinical and Vaccine Immunology

SN - 1556-6811

IS - 2

ER -